Pharma News

Researchers have developed a cost-effective one-step test that can screen, detect and confirm hepatitis C virus (HCV) infections from blood or urine samples. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.

Union Health Minister J.P. Nadda on Sunday inaugurated India's first retail facility at AIIMS to provide drugs for cancer and cardiovascular diseases at highly discounted rates.

Lead exposure in early in life is associated with increased risk of sleep problems and excessive daytime sleepiness in later childhood, says a new study.

Researchers have identified a drug that works to limit the spread of glioblastoma, the most common primary tumour of the brain and central nervous system which is also regarded as one of the most aggressive of all cancers.

The blind spot of the human eye can be shrunk with certain eye-training exercises, thus improving a person's vision slightly, a new study has found. The human eye includes an unavoidable blind spot. That is because the optic nerve that sends visual signals to the brain must pass through the retina, which creates a hole in that light-sensitive layer of tissue.

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.

Merck Animal Health (known as MSD Animal Health outside the United States and Canada) and Harrisvaccines, Inc., announced the companies have entered into an agreement under which Merck Animal Health will acquire Harrisvaccines, a privately-held company that develops, manufactures and sells vaccines for food production and companion animals.

The U.S. Food and Drug Administration approved Baxalta US Inc, Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Adynovate is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding.

Dr. Reddy’s Laboratories in a statement issued said that it has been made aware of an order passed by the District Court of Delaware, USA, granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of its generic esomeprazole product in the US market.

[adsense:336x280:8701650588]

Immune Pharmaceuticals Inc. announced that the US Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for its first in class, lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP). This FDA acceptance enables the company to expand recruitment for its clinical trials.